{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:57:32Z","timestamp":1767970652087,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.adro.2019.09.008","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T01:54:46Z","timestamp":1570672486000},"page":"189-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Clinical Outcomes Using Magnetic Resonance\u2013Guided Stereotactic Body Radiation Therapy in Patients With Locally Advanced Cholangiocarcinoma"],"prefix":"10.1016","volume":"5","author":[{"given":"Elaine","family":"Luterstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minsong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Raldow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6425-9228","authenticated-orcid":false,"given":"Daniel","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Percy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2019.09.008_bib1","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijrobp.2008.03.018","article-title":"Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma","volume":"72","author":"Shinohara","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.09.008_bib2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2008.09.017","article-title":"Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas","volume":"74","author":"Shinohara","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.09.008_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/PPO.0000000000000213","article-title":"Treatment selection and survival outcomes with and without radiation for unresectable, localized intrahepatic cholangiocarcinoma","volume":"22","author":"Jackson","year":"2016","journal-title":"Cancer J"},{"key":"10.1016\/j.adro.2019.09.008_bib4","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1245\/s10434-017-6131-9","article-title":"Chemoradiation therapy for unresected extrahepatic cholangiocarcinoma: A propensity score-matched analysis","volume":"24","author":"Torgeson","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2019.09.008_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.21037\/jgo.2018.01.15","article-title":"Chemoradiotherapy versus chemotherapy alone for unresected intrahepatic cholangiocarcinoma: Practice patterns and outcomes from the national cancer data base","volume":"9","author":"Verma","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.adro.2019.09.008_bib6","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/cncr.30488","article-title":"Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients","volume":"123","author":"Yamashita","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2019.09.008_bib7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.radonc.2018.09.010","article-title":"Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric","volume":"129","author":"Chang","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2019.09.008_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2016.07.020","article-title":"Stereotactic body radiotherapy for primary hepatic malignancies\u2013report of a phase I\/II institutional study","volume":"121","author":"Weiner","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2019.09.008_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1200\/JCO.2015.61.3778","article-title":"Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: A retrospective dose response analysis","volume":"34","author":"Tao","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2019.09.008_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","article-title":"Stereotactic body radiotherapy for unresectable cholangiocarcinoma","volume":"94","author":"Kopek","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2019.09.008_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1748-717X-7-67","article-title":"Clinical outcomes and toxicity using stereotactic body radiotherapy (SABR) for advanced cholangiocarcinoma","volume":"7","author":"Barney","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2019.09.008_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3857\/roj.2014.32.3.163","article-title":"Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma","volume":"32","author":"Da Hoon Jung","year":"2014","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.adro.2019.09.008_bib13","doi-asserted-by":"crossref","first-page":"93541","DOI":"10.18632\/oncotarget.19972","article-title":"Clinical outcomes and prognostic factors of stereotactic body radiation therapy for intrahepatic cholangiocarcinoma","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.adro.2019.09.008_bib14","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","article-title":"Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies","volume":"23","author":"Ben-Josef","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2019.09.008_bib15","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1002\/cam4.1734","article-title":"Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma","volume":"7","author":"Elganainy","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.adro.2019.09.008_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00066-018-1367-2","article-title":"Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: A meta-analysis and systematic review","volume":"195","author":"Lee","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2019.09.008_bib17","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ijrobp.2017.04.023","article-title":"Online adaptive radiation therapy","volume":"99","author":"Lim-Reinders","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.09.008_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.semradonc.2014.02.008","article-title":"The ViewRay system: Magnetic resonance\u2013guided and controlled radiotherapy","volume":"24","author":"Mutic","year":"2014","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.adro.2019.09.008_bib19","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phy"},{"key":"10.1016\/j.adro.2019.09.008_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.radonc.2018.08.009","article-title":"Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy","volume":"129","author":"Tyran","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2019.09.008_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.adro.2016.10.008","article-title":"Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma","volume":"1","author":"Sandler","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2019.09.008_bib22","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/j.ijrobp.2012.06.005","article-title":"Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies","volume":"84","author":"Bae","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109419301538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109419301538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:37:05Z","timestamp":1762529825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109419301538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2452109419301538"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2019.09.008","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes Using Magnetic Resonance\u2013Guided Stereotactic Body Radiation Therapy in Patients With Locally Advanced Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2019.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}